These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17617046)

  • 1. Innate alloimmunity: history and current knowledge.
    Land W
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking the toll of kidney disease.
    Shirali AC; Goldstein DR
    J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
    Palmer SM; Burch LH; Mir S; Smith SR; Kuo PC; Herczyk WF; Reinsmoen NL; Schwartz DA
    Clin Transplant; 2006; 20(1):30-6. PubMed ID: 16556150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
    Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
    Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1.
    McDaniel DO; Zhou X; Moore CK; Aru G
    Transplant Proc; 2010 Dec; 42(10):4235-7. PubMed ID: 21168672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.
    Land WG
    Transplantation; 2005 Mar; 79(5):505-14. PubMed ID: 15753838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injury to allografts: innate immune pathways to acute and chronic rejection.
    Land WG
    Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
    Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
    J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold ischaemia, innate immunity and deterioration of the glomerular filtration barrier in antibody-mediated acute rejection.
    Ripoll È; Nacher V; Vidal A; Herrero E; Bolaños N; Torras J; Grinyó JM; Ruberte J; Herrero-Fresneda I
    Nephrol Dial Transplant; 2012 Aug; 27(8):3296-305. PubMed ID: 22555253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.
    Braudeau C; Ashton-Chess J; Giral M; Dugast E; Louis S; Pallier A; Braud C; Moreau A; Renaudin K; Soulillou JP; Brouard S
    Transplantation; 2008 Jul; 86(1):130-6. PubMed ID: 18622290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):60-72. PubMed ID: 22000662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.